Editor’s note: This is an educational explainer about how UK rights issues and pre-emption rights generally work. It is general information, not investment advice, and does not describe any specific current event, company, or security.
A company announces it needs to raise fresh capital, and existing shareholders are offered new shares at a price well below where the stock currently trades. On the surface, that sounds like a straightforward gift. Yet the very same event, structured correctly, can also shrink the value of each share an investor already holds. How can one transaction simultaneously enrich and dilute the same shareholder? The answer lies in a legal mechanism baked into UK company law: the pre-emption right.
What a Rights Issue Actually Does
A rights issue is a way for a listed company to raise new equity capital by offering additional shares to its existing shareholders, typically in proportion to what they already own, at a price below the prevailing market price. A common structure might be described as “one new share for every four already held,” priced at a meaningful discount to the last traded price. The discount exists partly to compensate shareholders for the dilution that follows and partly to make the offer attractive enough that take-up is high, since the company is relying on that capital actually being raised.
Once the new shares are issued, the total number of shares in circulation increases. If the company’s underlying value has not changed, that same value is now spread across a larger number of shares, so in isolation, each individual share should be worth less than before. This is dilution in its purest form, and it applies to earnings per share, net asset value per share, and voting power alike. A shareholder who does nothing when a rights issue occurs, letting their entitlement lapse or simply ignoring it, will typically end up owning a smaller proportional stake in the company, even though they haven’t sold anything.
The Protective Half: Pre-emption Rights
This is where pre-emption rights come in, and they are the reason UK rights issues are structured so differently from a straightforward placing of new shares to outside investors. Under UK company law, principally the Companies Act 2006, a company generally cannot issue new shares for cash to new investors without first offering them to existing shareholders on the same terms, in proportion to their existing holdings. This statutory pre-emption right exists precisely to stop a board from quietly issuing cheap new equity to favoured parties and diluting everyone else out of their proportional stake without consent or compensation.
Because of pre-emption, every existing shareholder gets the first opportunity to buy the new shares at the discounted rights price, in proportion to what they already hold. If a shareholder takes up their full entitlement, spending the required cash to buy their allotted new shares, their percentage ownership of the company stays essentially unchanged, and the discount they received on the new shares offsets the dilution to the value of their existing holding. In effect, pre-emption converts a potential loss into a wash, and can leave a fully participating shareholder roughly where they started, mathematically speaking, once the discounted purchase is accounted for.
Why the Outcome Depends on the Shareholder’s Choice
The protective and dilutive effects therefore point in opposite directions, and which one dominates for a given investor comes down to participation. A shareholder who takes up their full rights entitlement is, broadly speaking, protected: the pre-emptive structure means they paid a discounted price for new shares that offsets the drop in value of their existing ones. A shareholder who does nothing experiences dilution without compensation, because the value transferred through the discount goes to whoever does buy the new shares rather than to them.
This is why UK rights issues typically include alternatives for shareholders who don’t want to, or can’t, put in fresh capital. Many rights issues allow non-participating shareholders to sell their “rights” (the entitlement to subscribe) on the market or through the company, a process sometimes called “tail swallowing,” which can provide at least partial compensation for the dilution rather than none at all. Underwriters are often involved to guarantee that any shares not taken up by shareholders are still sold, ensuring the company receives its target capital regardless of individual take-up rates.
Understood this way, a rights issue is less a single event than a structured choice presented to every shareholder simultaneously. The pre-emption right guarantees that the choice is offered fairly and proportionately; what an individual shareholder does with it determines whether the dilution that follows is offset, only partially compensated, or borne in full.